EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT
| Autor: | Merchant, Akil A. 1, Jorapur, Aparna 1, McManus, Amy 1, Liu, Ren 1, Krasnoperov, Valery 2, Chaudhry, Parvesh 1, Singh, Mohan 1, Harton, Lisa 1, Agajanian, Mary 1, Kim, Miriam 1, Triche, Timothy J., Jr 1, Druker, Brian J. 3, 4, 5, Tyner, Jeffrey W. 4, 6, Gill, Parkash S. 1 |
|---|---|
| Zdroj: | In Blood Advances 12 September 2017 1(20):1635-1644 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|